BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 10698492)

  • 1. EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes.
    Li R; Pei H; Watson DK; Papas TS
    Oncogene; 2000 Feb; 19(6):745-53. PubMed ID: 10698492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
    Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
    Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2.
    Wasylyk C; Bradford AP; Gutierrez-Hartmann A; Wasylyk B
    Oncogene; 1997 Feb; 14(8):899-913. PubMed ID: 9050989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of an intramolecular protein-protein interaction in c-Ets1 and its viral homologue v-Ets.
    Schmidt M; Schmidt AM; Dietl J; Kammerer U
    Oncol Rep; 2007 Aug; 18(2):457-63. PubMed ID: 17611671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical and functional interactions between Daxx and TSG101.
    Muromoto R; Sugiyama K; Yamamoto T; Oritani K; Shimoda K; Matsuda T
    Biochem Biophys Res Commun; 2004 Apr; 316(3):827-33. PubMed ID: 15033475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion.
    Yordy JS; Li R; Sementchenko VI; Pei H; Muise-Helmericks RC; Watson DK
    Oncogene; 2004 Aug; 23(39):6654-65. PubMed ID: 15247905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Ets function by protein - protein interactions.
    Li R; Pei H; Watson DK
    Oncogene; 2000 Dec; 19(55):6514-23. PubMed ID: 11175367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A variant form of ETS1 induces apoptosis in human colon cancer cells.
    Huang CC; Papas TS; Bhat NK
    Oncogene; 1997 Aug; 15(7):851-6. PubMed ID: 9266972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exon 4-encoded acidic domain in the epithelium-restricted Ets factor, ESX, confers potent transactivating capacity and binds to TATA-binding protein (TBP).
    Chang CH; Scott GK; Baldwin MA; Benz CC
    Oncogene; 1999 Jun; 18(25):3682-95. PubMed ID: 10391676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daxx-mediated transcriptional repression of MMP1 gene is reversed by SPOP.
    La M; Kim K; Park J; Won J; Lee JH; Fu YM; Meadows GG; Joe CO
    Biochem Biophys Res Commun; 2004 Jul; 320(3):760-5. PubMed ID: 15240113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic conversion alters the transcriptional properties of ets.
    Wasylyk C; Wasylyk B
    Cell Growth Differ; 1992 Sep; 3(9):617-25. PubMed ID: 1329927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative modulation of androgen receptor transcriptional activity by Daxx.
    Lin DY; Fang HI; Ma AH; Huang YS; Pu YS; Jenster G; Kung HJ; Shih HM
    Mol Cell Biol; 2004 Dec; 24(24):10529-41. PubMed ID: 15572661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
    Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
    Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural inferences of the ETS1 DNA-binding domain determined by mutational analysis.
    Mavrothalassitis G; Fisher RJ; Smyth F; Watson DK; Papas TS
    Oncogene; 1994 Feb; 9(2):425-35. PubMed ID: 8290254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter.
    Chen JH; Wright CD
    Oncogene; 1993 Dec; 8(12):3375-83. PubMed ID: 8247540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ets-2 interacts with co-repressor BS69 to repress target gene expression.
    Wei G; Schaffner AE; Baker KM; Mansky KC; Ostrowski MC
    Anticancer Res; 2003; 23(3A):2173-8. PubMed ID: 12894593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the DNA binding and transcriptional activation properties of the Ets1 oncoprotein.
    Gegonne A; Punyammalee B; Rabault B; Bosselut R; Seneca S; Crabeel M; Ghysdael J
    New Biol; 1992 May; 4(5):512-9. PubMed ID: 1515415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for gene evolution of the ets-1/ets-2 transcription factors based on structural and functional homologies.
    Albagli O; Soudant N; Ferreira E; Dhordain P; Dewitte F; Begue A; Flourens A; Stehelin D; Leprince D
    Oncogene; 1994 Nov; 9(11):3259-71. PubMed ID: 7936650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
    Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
    Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FEV acts as a transcriptional repressor through its DNA-binding ETS domain and alanine-rich domain.
    Maurer P; T'Sas F; Coutte L; Callens N; Brenner C; Van Lint C; de Launoit Y; Baert JL
    Oncogene; 2003 May; 22(21):3319-29. PubMed ID: 12761502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.